Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06744283
What this trial is testing

Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia

Who this might be right for
Fanconi Anemia
National Cancer Institute (NCI) 20
Early research (Phase 1)WithdrawnNCT05823480
What this trial is testing

Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center
Early research (Phase 1)Study completedNCT00931931
What this trial is testing

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors

Who this might be right for
RhabdomyosarcomaOsteosarcomaEwing Sarcoma+6 more
Timothy Cripe 18
Not applicableStudy completedNCT02487069
What this trial is testing

Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy

Who this might be right for
Acute LeukemiaChronic Myeloid LeukemiaMyelodysplastic Syndrome
Nanfang Hospital, Southern Medical University 876
Testing effectiveness (Phase 2)Ended earlyNCT02657005
What this trial is testing

TK216 in Patients With Relapsed or Refractory Ewing Sarcoma

Who this might be right for
Sarcoma, Ewing
Oncternal Therapeutics, Inc 85
Early research (Phase 1)Not Yet RecruitingNCT07529951
What this trial is testing

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

Who this might be right for
Polycythemia Vera (PV)Myelofibrosis (MF)
Eilean Therapeutics 60
Testing effectiveness (Phase 2)UnknownNCT02688686
What this trial is testing

Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases

Who this might be right for
Non-Small-Cell Lung Cancer With Bone Metastases
Affiliated Hospital to Academy of Military Medical Sciences 30
Large-scale testing (Phase 3)Ended earlyNCT03547154
What this trial is testing

Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)

Who this might be right for
Chronic Myelogenous Leukemia
Merck Sharp & Dohme LLC 344
Testing effectiveness (Phase 2)Study completedNCT01286077
What this trial is testing

Velcade Consolidation Bone Study

Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 106
Testing effectiveness (Phase 2)Looking for participantsNCT07357519
What this trial is testing

Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)

Who this might be right for
Relapsed / Refractory Osteosarcoma
Lantheus Medical Imaging 55
Not applicableStudy completedNCT02376127
What this trial is testing

Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion

Who this might be right for
Solid CancerMetastatic Spinal Lesions
Memorial Sloan Kettering Cancer Center 25
Not applicableStudy completedNCT00080873
What this trial is testing

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Children's Oncology Group 195
Early research (Phase 1)WithdrawnNCT05456269
What this trial is testing

Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS

Who this might be right for
Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+2 more
Racura Oncology Ltd
Not applicableStudy completedNCT02800954
What this trial is testing

Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire, Amiens 111
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Not applicableStudy completedNCT05772312
What this trial is testing

Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery

Who this might be right for
Sarcoma, EwingOsteosarcomaBone Tumor
Istituto Ortopedico Rizzoli 41
Testing effectiveness (Phase 2)Study completedNCT00003146
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Not applicableActive Not RecruitingNCT04167683
What this trial is testing

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

Who this might be right for
Hematologic DiseasesChronic Myeloid LeukemiaAcute Myeloid Leukemia+5 more
Rigshospitalet, Denmark 144
Early research (Phase 1)Study completedNCT00038051
What this trial is testing

Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyeloproliferative Disorders+1 more
M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT02017457
What this trial is testing

Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Carlos Graux, MD, PhD 50
Next Page